Use of a bio-electronic device comprising of targeted dual neuromodulation of the hepatic and celiac vagal branches demonstrated enhanced glycemic control in a type 2 diabetic rat model as well as in an Alloxan treated swine model
Jonathan J. Waataja, Raj K. Nihalani, C. N. Honda, C. Billington
Frontiers in Neuroscience